Starling Oncology STLN
NASDAQ STLN
$6.22 -0.11 (-1.66%)
At close: Oct 1, 2026 · 4:00 PM EDT

Starling Oncology (STLN) Preferred Stock Liabilities (2020 - 2021)

Updated

Starling Oncology's Preferred Stock Liabilities came in at $230 million for Q3 2021, up 13.0% from $203.49 million a year earlier and up 14.7% from the prior quarter.

Analysis

Starling Oncology (STLN) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

Going back to Q1 2020, Starling Oncology's Preferred Stock Liabilities data covers 7 quarters.

  • Business Quant data shows STLN's Preferred Stock Liabilities at $200.53 million (Q2 2021), $206.65 million (Q1 2021) and $230 million (Q4 2020) in the three quarters before Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 HCA Healthcare 93.06 Bn 92.50 Bn - -
2 Natera 59.36 Bn 55.04 Bn 485.19 Mn -
3 Quest Diagnostics 25.72 Bn 24.15 Bn 1.03 Bn -
4 Labcorp Holdings 24.93 Bn 22.69 Bn 1.11 Bn -
5 Guardant Health 23.83 Bn 19.89 Bn 219.03 Mn -
6 Tenet Healthcare 20.58 Bn 11.72 Bn - -
7 Tempus AI 14.35 Bn 11.38 Bn 246.50 Mn -
8 Encompass Health 11.99 Bn 12.46 Bn - -
9 BrightSpring Health Services 11.21 Bn 9.55 Bn 492.75 Mn -
10 Starling Oncology 634.96 Mn 502.37 Mn 27.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 230.00 Mn
Jun 30, 2021 200.53 Mn
Mar 31, 2021 206.65 Mn
Dec 31, 2020 230.00 Mn
Sep 30, 2020 203.49 Mn
Jun 30, 2020 205.91 Mn
Mar 31, 2020 230.00 Mn
API Access

Starling Oncology Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=STLN&period=max&api_key=YOUR_API_KEY